Showing results (1011-1020 of 1,038) with videos related to
Sort By:
Pageof 104
Bioorganic & Medicinal Chemistry Letters|June 14, 2023
Structure-activity relationship study of central pyridine-derived TYK2 JH2 inhibitors: Optimization of the PK profile through C4' and C6 variationsZili Xiao, Michael G Yang, Chunjian Liu, et al.Head & Neck|September 28, 2012
Transoral resection of pharyngeal cancer: summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6-7, 2011, Arlington, VirginiaDavid J Adelstein, John A Ridge, David M Brizel, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 29, 2013
Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral ResearchElizabeth Shane, David Burr, Bo Abrahamsen, et al.Science Translational Medicine|July 26, 2019
Autoimmune pathways in mice and humans are blocked by pharmacological stabilization of the TYK2 pseudokinase domainJames R Burke, Lihong Cheng, Kathleen M Gillooly, et al.ACS Medicinal Chemistry Letters|March 21, 2019
Identification of Imidazo[1,2-b]pyridazine Derivatives as Potent, Selective, and Orally Active Tyk2 JH2 InhibitorsChunjian Liu, James Lin, Ryan Moslin, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 16, 2010
Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral ResearchElizabeth Shane, David Burr, Peter R Ebeling, et al.Journal of Medicinal Chemistry|September 18, 2025
Identification of VVD-214/RO7589831, a Clinical-Stage, Covalent Allosteric Inhibitor of WRN Helicase for the Treatment of MSI-High CancersShota Kikuchi, Jason C Green, Don C Rogness, et al.Cancer Research|June 8, 2023
The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate CancerArian Lundberg, Meng Zhang, Rahul Aggarwal, et al.Journal of Medicinal Chemistry|July 19, 2019
Highly Selective Inhibition of Tyrosine Kinase 2 (TYK2) for the Treatment of Autoimmune Diseases: Discovery of the Allosteric Inhibitor BMS-986165Stephen T Wrobleski, Ryan Moslin, Shuqun Lin, et al.Nature Genetics|July 17, 2024
Integrated analyses highlight interactions between the three-dimensional genome and DNA, RNA and epigenomic alterations in metastatic prostate cancerShuang G Zhao, Matthew Bootsma, Stanley Zhou, et al.Pageof 104